News
Polio: Public Health Emergency of International Concern
An update on the polio Public Health Emergency of International Concern (PHEIC)
Factsheets
Poliomyelitis
Poliomyelitis (polio) is a potentially paralysing viral infection that only occurs in humans
Polio vaccination certificate
How to complete an International Certificate of Vaccination or Prophylaxis (ICVP) for polio
Topics
Polio
Poliomyelitis is a potentially paralysing, vaccine preventable, viral infection transmitted through food or water contaminated by infected human faeces or by direct contact with an infectious person
Outbreaks
cVDPV2 in South Sudan
As of 18 December 2024, a total of nine cirulating vaccine-derived poliovirus type 2 (cVDPV2) cases have been reported in 2024. Please see our polio in brief article below for further details on polio.
VDPV2 in Finland
On 9 December 2024, vaccine-derived poliovirus type 2 (VDPV2) was reported to be detected in wastewater samples in Tampere. Please see our Topics in Brief article for further details on polio.
Leeds
West Sussex
VDPV2 in United Kingdom
Vaccine-derived poliovirus type 2 (VDPV2) has been detected in environmental sewage samples from Leeds (two samples), London (one sample) and West Sussex (one sample) during November 2024. To date there is no evidence of community transmission and the risk to the public is low. Please see our Topics in Brief article for further details on polio.
Bonn
Cologne
Munich
cVDPV2 in Germany
During the week ending 4 December 2024, four cVDPV2-positive environmental samples collected in October and November 2024 were reported from Germany across Munich, Bonn, Cologne and Hamburg. Please see our Topics in Brief article for further details on polio.
cVDPV2 in Poland
As of 20 November 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample from Warsaw. This sample is linked to the cVDPV2 oubreak originating in Zamfara, northern Nigeria. Please see our Topics in Brief article for further details on polio.
cVDPV3 in Guinea
Three cases of circulating vaccine-derived poliovirus type 3 (cVDPV3) have been reported from Kankan, Guinea, with onsets of paralysis in July, August, and September 2024. These are the first cVDPV3 cases reported in this country. Please see our Topics in Brief article for further details on polio.
cVDPV2 in Djibouti
As of 23 October 2024, one positive circulating vaccine-derived poliovirus type 2 (cVDPV2) environmental sample has been reported in Djibouti. The sample was collected in September, making it the first in the country since May 2022.
cVDPV3 in French Guiana
As of 9 October 2024, circulating vaccine-derived poliovirus type 3 (cVDPV3) has been detected in three environmental samples collected in May, June and August 2024. This is the first time cVDPV3 has been reported in French Guiana.
cVDPV2 in Spain
As of 9 October 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample from the Barcelona metropolitan area, Catalonia. This is the first time cVDPV2 has been reported in Spain.
cVDPV2 in Ghana
As of 11 September 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Palestinian Territories
As of 28 August 2024, a ciruclating vaccine-derived polio virus type 2 (cVDPV2) case was reported in the Gaza Strip. There have been six cVDPV2-positive environmental samples reported in Gaza this year.
cVDPV2 in Liberia
As of 14 August, a case of circulating vaccine-derived polio virus type 2 (cVDPV2) was reported in Sinoe. This is the first case reported since 2021.
cVDPV2 in Ghana
As of 16 June 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Uganda
As of 7 June 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in The Gambia
As of 7 June 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
Gambela
Amhara
Tigray
cVDPV2 in Ethiopia
As of 22 May 2024, six cVDPV2 cases were reported in Ethiopia; one each in Tigray and Afar and two each in Gambella and Amhara. There was one cVDPV2 case reported in 2023 and 5 cases in 2024.
cVDPV2 in Angola
As of 8 May 2024, one case of circulating vaccine-derived poliovirus type 2 (cVDPV2) has been reported. This is the first human case reported in Angola since 2022.
cVDPV2 in Liberia
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Senegal
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Sierra Leone
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
Luanda
cVDPV2 in Angola
As of 13 March 2024, two circulating vaccine-derived poliovirus type 2 (cVDPV2) positive environmental samples were reported in Huambo and Luanda.
cVDPV2 in Zimbabwe
As of 24 January 2024 one case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported. The case was reported from Mashonaland West, and occurred in December 2023.
East Java Jawa Timur
cVDPV2 in Indonesia
As of 4 January 2024, the Indonesian Ministry of Health reported three human cases of circulating vaccine-derived poliovirus type 2 (cVDPV2). Two cases were detected in Central Java and East Java in December 2023, with one other case reported in East Java on 4 January 2024.
cVDPV2 in Zambia
As of 26 December 2023, four human cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported in Zambia for 2023.
cVDPV2 in Mauritania
A confirmed circulating vaccine-derived poliovirus type 2 (cVDPV2) has been isolated from an environmental sample, collected on 6 September 2023. This is the first cVDPV2 in the country since December 2021.
